309 related articles for article (PubMed ID: 19496088)
1. Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control.
Radermecker RP; Renard E; Scheen AJ
Diabetes Metab Res Rev; 2009 Sep; 25(6):491-501. PubMed ID: 19496088
[TBL] [Abstract][Full Text] [Related]
2. Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues.
Radermecker RP; Scheen AJ
Diabetes Metab Res Rev; 2007 Jul; 23(5):348-55. PubMed ID: 17216593
[TBL] [Abstract][Full Text] [Related]
3. Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies.
Lassmann-Vague V; Belicar P; Alessis C; Raccah D; Vialettes B; Vague P
Diabet Med; 1996 Dec; 13(12):1051-5. PubMed ID: 8973887
[TBL] [Abstract][Full Text] [Related]
4. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
[TBL] [Abstract][Full Text] [Related]
5. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
6. Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII).
Shashaj B; Busetto E; Sulli N
Diabet Med; 2008 Sep; 25(9):1036-42. PubMed ID: 18937673
[TBL] [Abstract][Full Text] [Related]
7. [Hypoglycemia and transient diabetes mellitus in an insulin autoimmune syndrome].
Reisch N; Zwermann O; Reincke M
Dtsch Med Wochenschr; 2004 May; 129(20):1135-8. PubMed ID: 15143456
[TBL] [Abstract][Full Text] [Related]
8. Treatment of diabetes mellitus using an external insulin pump in clinical practice.
Jeandidier N; Riveline JP; Tubiana-Rufi N; Vambergue A; Catargi B; Melki V; Charpentier G; Guerci B
Diabetes Metab; 2008 Sep; 34(4 Pt 2):425-38. PubMed ID: 18951117
[TBL] [Abstract][Full Text] [Related]
9. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
[TBL] [Abstract][Full Text] [Related]
10. Replacement treatment with insulin in diabetes mellitus: problems and promise.
Dupre J; Champion MC; Rodger NW
Clin Invest Med; 1982; 5(2-3):109-19. PubMed ID: 6749365
[TBL] [Abstract][Full Text] [Related]
11. A case of slowly progressive type 1 diabetes with unstable glycemic control caused by unusual insulin antibody and successfully treated with steroid therapy.
Matsuyoshi A; Shimoda S; Tsuruzoe K; Taketa K; Chirioka T; Sakamoto F; Sakakida M; Miyamura N; Araki E
Diabetes Res Clin Pract; 2006 Jun; 72(3):238-43. PubMed ID: 16439034
[TBL] [Abstract][Full Text] [Related]
12. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy.
Bruttomesso D; Costa S; Baritussio A
Diabetes Metab Res Rev; 2009 Feb; 25(2):99-111. PubMed ID: 19172576
[TBL] [Abstract][Full Text] [Related]
13. Clinical disorders associated with autoantibodies to the insulin receptor. Simulation by passive transfer of immunoglobulins to rats.
Dons RF; Havlik R; Taylor SI; Baird KL; Chernick SS; Gorden P
J Clin Invest; 1983 Sep; 72(3):1072-80. PubMed ID: 6350362
[TBL] [Abstract][Full Text] [Related]
14. Lower rate of initial failures and reduced occurrence of adverse events with a new catheter model for continuous subcutaneous insulin infusion: prospective, two-period, observational, multicenter study.
Renard E; Guerci B; Leguerrier AM; Boizel R;
Diabetes Technol Ther; 2010 Oct; 12(10):769-73. PubMed ID: 20809682
[TBL] [Abstract][Full Text] [Related]
15. Clinical application of pre-programmed insulin infusion: continuous subcutaneous insulin therapy with a portable infusion system.
Pickup JC; Viberti GC; Keen H; Parsons JA; Alberti KG
Horm Metab Res Suppl; 1979; (8):202-4. PubMed ID: 395081
[TBL] [Abstract][Full Text] [Related]
16. Insulin pump therapy (continuous subcutaneous insulin infusion).
White RD
Prim Care; 2007 Dec; 34(4):845-71, vii. PubMed ID: 18061820
[TBL] [Abstract][Full Text] [Related]
17. [Continuous predetermined insulin infusion in insulin-dependent diabetes mellitus (author's transl)].
Jean R; Rolin B
Sem Hop; 1982 Jan; 58(2):123-6. PubMed ID: 6276997
[TBL] [Abstract][Full Text] [Related]
18. Technology of pre-programmable insulin delivery systems: continuous subcutaneous insulin infusion.
Pickup JC; Keen H; Parsons JA; Alberti KG
Horm Metab Res Suppl; 1979; (8):49-51. PubMed ID: 395089
[TBL] [Abstract][Full Text] [Related]
19. Hyperglycaemia in acute stroke--to treat or not to treat.
Quinn TJ; Lees KR
Cerebrovasc Dis; 2009; 27 Suppl 1():148-55. PubMed ID: 19342845
[TBL] [Abstract][Full Text] [Related]
20. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration.
Quellhorst E
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
